About Us:
Structure Therapeutics develops life‐changing medicines for patients using advanced structure‐based and computational drug discovery technology. The company’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical‐stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions.
Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company completed an initial public offering (IPO) in February 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location.
Position Summary
He/She will lead the design, execution, and interpretation of in vivo pharmacology studies to support drug discovery programs. This role transitions from hands-on execution to scientific leadership, including experimental design, complex problem solving, and program-level contribution.
The individual will ensure high standards of data quality, oversee internal QC practices, and contribute to IND-enabling activities. The role also supports lab operations and continuous improvement of workflows to ensure efficiency and compliance.
Job Responsibilities:
Qualifications:
Core Competencies, Knowledge, and Skills
Education and Experience